Stories tagged: prostate cancer
THURSDAY, OCT. 13, 2016, 5:15 P.M.
Prostate cancer and dementia: Do hormone blockers boost risks?
Hormone-blocking drugs for prostate cancer may increase men’s chances for developing dementia, a large study suggests.
TUESDAY, OCT. 4, 2016, 3:28 P.M.
Ben Stiller credits prostate cancer test for saving his life
Ben Stiller on Tuesday revealed that he battled prostate cancer in 2014, and he credits the test that diagnosed the cancer with saving his life.
WEDNESDAY, SEPT. 14, 2016, 2:55 P.M.
Treat or monitor early prostate cancer? 10-year survival same
Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds …
MONDAY, AUG. 22, 2016, 12:45 P.M.
Pfizer to pay $14 billion for Medivation
Pharmaceutical giant Pfizer Inc. is paying $14 billion to buy Medivation Inc., a San Francisco biotech company that sells a high-priced prostate cancer medication discovered by UCLA.
TUESDAY, AUG. 18, 2015
Choice of PSA tests a personal one
Prostate cancer kills more than 20,000 men every year. The U.S. Preventive Services Task Force gave prostate-specific antigen testing and its attendant (and not much fun) rectal examination a flunking …
TUESDAY, JUNE 19, 2012
Heaps of positive energy
As a runner who completed the 50-mile Le Grizz Ultramarathon in Montana as a younger man – and then did it 19 more times – Steve Heaps is slower than …
MONDAY, JUNE 7, 2010
Radiation enhances prostate cancer treatment
CHICAGO – Doctors are reporting a key advance in treating men with cancer that has started to spread beyond the prostate: Survival is significantly better if radiation is added to …
FRIDAY, APRIL 30, 2010
Prostate cancer therapy OK’d by FDA
LOS ANGELES – The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The …
THURSDAY, APRIL 1, 2010
Drug may shrink risk of prostate cancer
LOS ANGELES – Men at an above-normal risk of prostate cancer may be able to reduce their risk of developing the disease by taking a drug already on the market. …
TUESDAY, SEPT. 22, 2009
Wait, see approach to prostate cancer
For men over age 65, doing nothing to treat localized, nonaggressive prostate cancer may be the best policy, according to major new research. Survival rates have improved to 94 percent …
WEDNESDAY, APRIL 29, 2009
Approval of prostate vaccine urged
A controversial prostate cancer vaccine that previously had been rejected by the Food and Drug Administration improves survival of patients with the advanced form of the disease more than existing …
WEDNESDAY, APRIL 15, 2009
Prostate treatment study shows improved survival
An experimental treatment that takes an entirely new approach to fighting prostate cancer extended survival in a late-stage study, its maker announced Tuesday. Seattle-based Dendreon Corp. said that its Provenge …
TUESDAY, MARCH 3, 2009
More doctors advising wait-and-see for some prostate cancers
BALTIMORE – When Peter Bentey was diagnosed with prostate cancer, the doctor told him that he needed surgery. So did the doctor who gave him a second opinion. And the …
WEDNESDAY, FEB. 25, 2009
Finasteride may benefit prostate health, NIH says
Healthy men older than 55 who are concerned enough about the risk of prostate cancer to undergo annual PSA screening should consider taking the drug finasteride daily to reduce their …